Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 5804-5810

  Saising, Jongkon ^a,b   Dube, Linda ^a   Ziebandt, Anne Kathrin ^a   Voravuthikunchai, Supayang Piyawan ^b   Nega, Mulugeta ^a   Götz, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; AUTOLYSIN; GALLIDERMIN;

ARTICLE; BACTERIAL GROWTH; BIOFILM; CELL ACTIVITY; CELL SUBPOPULATION; CELL SURVIVAL; CELL VIABILITY; DOSE RESPONSE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ADHESINS, BACTERIAL; BACTERIOCINS; BIOFILMS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84868035975     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01296-12     Document Type: Article

References (55)

1. Augustin J, et al. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149-1154.
2. Bera A, et al. 2007. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J. Bacteriol. 189:280-283.
3. Bierbaum G, Brötz H, Koller KP, Sahl HG. 1995. Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol. Lett. 127: 121-126.
4. Bonelli RR, Schneider T, Sahl HG, Wiedemann I. 2006. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 50:1449-1457.
5. Brötz H, et al. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
6. Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, CLSI document M7-A7, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Cramton SE, Gerke C, Götz F. 2001. In vitro methods to study staphylococcal biofilm formation. Methods Enzymol. 336:239-255.
8. Cramton SE, Gerke C, Schnell NF, Nichols WW, Götz F. 1999. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun. 67:5427-5433.
9. Diep BA, et al. 2006. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 367:731-739.
10. Ernst CM, et al. 2009. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 5:e1000660. doi:10.1371/journal. ppat.1000660.
11. Frank KL, Reichert EJ, Piper KE, Patel R. 2007. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob. Agents Chemother. 51:888-895.
12. Freund S, et al. 1991. The solution structure of the lantibiotic gallidermin. Biopolymers 31:803-811.
13. Fuchs S, Pane-Farre J, Kohler C, Hecker M, Engelmann S. 2007. Anaerobic gene expression in Staphylococcus aureus. J. Bacteriol. 189: 4275-4289.
14. Geissler S, Götz F, Kupke T. 1996. Serine protease EpiP from Staphylococcus epidermidis catalyzes the processing of the epidermin precursor peptide. J. Bacteriol. 178:284-288.
15. Gerke C, Kraft A, Sussmuth R, Schweitzer O, Götz F. 1998. Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. J. Biol. Chem. 273:18586-18593.
16. B-dependent transcription of sigB and asp23 in two different Staphylococcus aureus strains. Mol. Gen. Genet. 261:558-566.
17. Götz F. 2004. Staphylococci in colonization and disease: prospective targets for drugs and vaccines. Curr. Opin. Microbiol. 7:477-487.
18. Götz F. 2002. Staphylococcus and biofilms. Mol. Microbiol. 43:1367-1378.
19. Götz F, Peters G. 2000. Colonization of medical devices by coagulase-negative staphylococci, p 55-88. In Waldvogel FA, Bisno AL (ed), Infections associated with indwelling medical devices, 3rd ed. ASM Press, Washington, DC.
20. Gould IM, et al. 2012. New insights into methicillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents 39:96-104.
21. Heilmann C, Hussain M, Peters G, Götz F. 1997. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 24:1013-1024.
22. Heilmann C, et al. 1996. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 20:1083-1091.
23. Hsu CY, et al. 2011. Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 63: 236-247.
24. Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. 2006. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob. Agents Chemother. 50:1463-1469.
25. Kellner R, et al. 1988. Gallidermin: a new lanthionine-containing polypeptide antibiotic. Eur. J. Biochem. 177:53-59.
26. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. 2004. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
27. Köhler T, Weidenmaier C, Peschel A. 2009. Wall teichoic acid protects Staphylococcus aureus against antimicrobial fatty acids from human skin. J. Bacteriol. 191:4482-4484.
28. Kuehl R, et al. 2009. Furanone at subinhibitory concentrations enhances staphylococcal biofilm formation by luxS repression. Antimicrob. Agents Chemother. 53:4159-4166.
29. Kuipers OP, Beerthuyzen MM, Siezen RJ, De Vos WM. 1993. Characterization of the nisin gene cluster nisABTCIPR of Lactococcus lactis. Requirement of expression of the nisA and nisI genes for development of immunity. Eur. J. Biochem. 216:281-291.
30. Kupke T, Götz F. 1996. Post-translational modifications of lantibiotics. Antonie van Leeuwenhoek 69:139-150.
31. Kupke T, Kempter C, Gnau V, Jung G, Götz F. 1994. Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD. J. Biol. Chem. 269:5653-5659.
32. Kwiecinski J, Eick S, Wojcik K. 2009. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase. Int. J. Antimicrob. Agents 33:343-347.
33. Mack D, et al. 1996. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked gluco-saminoglycan: purification and structural analysis. J. Bacteriol. 178:175-183.
34. Majumdar D, Avissar YJ, Wyche JH. 1991. Simultaneous and rapid isolation of bacterial and eukaryotic DNA and RNA: a new approach for isolating DNA. Biotechniques 11:94-101.
35. Müller A, Ulm H, Reder-Christ K, Sahl HG, Schneider T. 2012. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. Microb. Drug Resist. 18:261-270.
36. Niu WW, Neu HC. 1991. Activity of mersacidin, a novel peptide, compared with that ofvancomycin, teicoplanin, and daptomycin. Antimicrob. Agents Chemother. 35:998-1000.
37. Nostro A, et al. 2007. Effects of oregano, carvacrol and thymol on Staph-ylococcus aureus and Staphylococcus epidermidis biofilms. J. Med. Microbiol. 56:519-523.
38. Oduwole KO, et al. 2010. Anti-biofilm activity of sub-inhibitory povidone iodine concentrations against Staphylococcus epidermidis and Staph-ylococcus aureus. J. Orthop. Res. 28:1252-1256.
39. Ottenwälder B, et al. 1995. Isolation and characterization of genetically engineered gallidermin and epidermin analogs. Appl. Environ. Microbiol. 61:3894-3903.
40. Peng ZX, et al. 2011. Quaternized chitosan inhibits icaA transcription and biofilm formation by Staphylococcus on a titanium surface. Antimi-crob. Agents Chemother. 55:860-866.
41. Peschel A, Augustin J, Kupke T, Stevanovic S, Götz F. 1993. Regulation of epidermin biosynthetic genes by EpiQ. Mol. Microbiol. 9:31-39.
42. Peschel A, Götz F. 1996. Analysis of the Staphylococcus epidermidis genes epiF, -E, and -G involved in epidermin immunity. J. Bacteriol. 178:531-536.
43. Peschel A, Ottenwälder B, Götz F. 1996. Inducible production and cellular location of the epidermin biosynthetic enzyme EpiB using an improved staphylococcal expression system. FEMS Microbiol. Lett. 137: 279-284.
44. Peschel A, et al. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivitytodefensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405-8410.
45. Peschel A, Schnell N, Hille M, Entian KD, Götz F. 1997. Secretion of the lantibiotics epidermin and gallidermin: sequence analysis of the genes gdmT and gdmH, their influence on epidermin production and their regulation by EpiQ. Mol. Gen. Genet. 254:312-318.
46. Rachid S, Ohlsen K, Witte W, Hacker J, Ziebuhr W. 2000. Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis. Antimicrob. Agents Chemother. 44:3357-3363.
47. Saising J, Ongsakul M, Voravuthikunchai SP. 2011. Rhodomyrtus tomentosa (Aiton) Hassk ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci. J. Med. Microbiol. 60:1793-1800.
48. Schlag M, et al. 2010. Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl. Mol. Microbiol. 75:864-873.
49. Schnell N, et al. 1992. Analysis of genes involved in the biosynthesis of lantibiotic epidermin. Eur. J. Biochem. 204:57-68.
50. Schnell N, et al. 1991. The operon-like organisation of lantibiotic epidermin biosynthesis genes, p 269-276. In Jung G, Sahl H-G (ed), Nisin and novel lantibiotics. ESCOM, Leiden, The Netherlands.
51. Schnell N, et al. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278.
52. von Eiff C, et al. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179: 4706-4712.
53. Wang Q, et al. 2010. Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob. Agents Chemother. 54: 2707-2711.
54. Wang XQ, et al. 2009. Effect of berberine on Staphylococcus epidermidis biofilm formation. Int. J. Antimicrob. Agents 34:60-66.
55. Weidenmaier C, et al. 2004. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 10:243-245.